Literature DB >> 173386

Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.

R W Gange, A de Bats, J R Park, C M Bradstreet, E L Rhodes.   

Abstract

Cellular immune responses and circulating antibody levels to herpes simplex virus were examined in patients with recurrent herpes simplex (HSV) infections and controls. Mixed leukocyte migration inhibition by herpes simplex antigen was less in affected patients than in controls but serum antibody levels were higher. There was no significant difference in leukocyte migration between patients with active or recent lesions and other herpes subjects, and the response in the mixed leukocyte migration test to phytohaemagglutinin (PHA) was similar in patients and controls. The data presented suggest that a localized defect in cell mediated immunity to herpes simplex virus may exist and be responsible for recurrent herpes simplex infections.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173386     DOI: 10.1111/j.1365-2133.1975.tb02246.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].

Authors:  S W Wassilew; I Koch
Journal:  Arch Dermatol Res       Date:  1978-08-28       Impact factor: 3.017

2.  Pathogenetic mechansims of recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

3.  Leukocyte migration inhibitory factor in primary and recurrent ocular infections by herpes simplex-virus.

Authors:  G Grabner; R Jarisch
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-07-02

4.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors.

Authors:  H Moser; F Behrens; R Ziegelmaier; J Hilfenhaus; R Mauler
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

6.  Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.

Authors:  A D Donnenberg; E Chaikof; L Aurelian
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.

Authors:  E J Shillitoe; J M Wilton; T Lehner
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

8.  [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].

Authors:  R Jarisch; I Sandor
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.